Works matching Hormone receptor positive breast cancer

Results: 4279
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11

    TBCRC 002: a phase II, randomized, open-label trial of preoperative letrozole with or without bevacizumab in postmenopausal women with newly diagnosed stage 2/3 hormone receptor-positive and HER2-negative breast cancer.

    Published in:
    2020
    By:
    • Vaklavas, Christos;
    • Roberts, Brian S.;
    • Varley, Katherine E.;
    • Lin, Nancy U.;
    • Liu, Minetta C.;
    • Rugo, Hope S.;
    • Puhalla, Shannon;
    • Nanda, Rita;
    • Storniolo, Anna Maria;
    • Carey, Lisa A.;
    • Saleh, Mansoor N.;
    • Li, Yufeng;
    • Delossantos, Jennifer F.;
    • Grizzle, William E.;
    • LoBuglio, Albert F.;
    • Myers, Richard M.;
    • Forero-Torres, Andres;
    • Translational Breast Cancer Research Consortium (TBCRC)
    Publication type:
    journal article
    12
    13
    14
    15

    Trastuzumab and fulvestrant combination therapy for women with advanced breast cancer positive for hormone receptor and human epidermal growth factor receptor 2: a retrospective single-center study.

    Published in:
    2022
    By:
    • Ozaki, Yukinori;
    • Aoyama, Yosuke;
    • Masuda, Jun;
    • Inagaki, Lina;
    • Kawai, Saori;
    • Shibayama, Tomoko;
    • Maeda, Tetsuyo;
    • Kurata, Mami;
    • Yoshida, Kazuyo;
    • Saeki, Sumito;
    • Hosonaga, Mari;
    • Fukada, Ippei;
    • Hara, Fumikata;
    • Kobayashi, Takayuki;
    • Kobayashi, Kokoro;
    • Miyake, Satoshi;
    • Takano, Toshimi;
    • Ueno, Takayuki;
    • Ohno, Shinji
    Publication type:
    journal article
    16
    17
    18
    19
    20
    21

    Capecitabine Plus Aromatase Inhibitor as First Line Therapy for Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer.

    Published in:
    Current Oncology, 2023, v. 30, n. 7, p. 6097, doi. 10.3390/curroncol30070454
    By:
    • Alvarado-Miranda, Alberto;
    • Lara-Medina, Fernando Ulises;
    • Muñoz-Montaño, Wendy R.;
    • Zinser-Sierra, Juan W.;
    • Galeana, Paula Anel Cabrera;
    • Garza, Cynthia Villarreal;
    • Sanchez Benitez, Daniel;
    • Limón Rodríguez, Jesús Alberto;
    • Arce Salinas, Claudia Haydee;
    • Guijosa, Alberto;
    • Arrieta, Oscar
    Publication type:
    Article
    22
    23
    24

    High tumour-infiltrating lymphocytes correlate with distinct gene expression profile and favourable survival in single hormone receptor-positive breast cancer.

    Published in:
    Contemporary Oncology / Współczesna Onkologia, 2024, v. 28, n. 1, p. 75, doi. 10.5114/wo.2024.139375
    By:
    • Ciarka, Aleksandra;
    • Kunc, Michał;
    • Popęda, Marta;
    • Łacko, Aleksandra;
    • Radecka, Barbara;
    • Braun, Marcin;
    • Pikiel, Joanna;
    • Litwiniuk, Maria;
    • Pogoda, Katarzyna;
    • Iżycka-Świeszewska, Ewa;
    • Zeller, Anna;
    • Niemira, Magdalena;
    • Pęksa, Rafał;
    • Biernat, Wojciech;
    • Senkus, Elżbieta
    Publication type:
    Article
    25
    26
    27
    28
    29
    30

    Capecitabine in Combination with Endocrine Therapy as Maintenance Therapy after Bevacizumab Plus Paclitaxel Induction Therapy for Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: KBCSG-TR1214.

    Published in:
    Cancers, 2021, v. 13, n. 17, p. 4399, doi. 10.3390/cancers13174399
    By:
    • Masuda, Norikazu;
    • Yoshinami, Tetsuhiro;
    • Ikeda, Masahiko;
    • Mizutani, Makiko;
    • Yamaguchi, Miki;
    • Komoike, Yoshifumi;
    • Takashima, Tsutomu;
    • Yoshidome, Katsuhide;
    • Tsurutani, Junji;
    • Iwamoto, Mitsuhiko;
    • Fujisawa, Fumie;
    • Yasojima, Hiroyuki;
    • Yamamura, Jun;
    • Morishima, Hirotaka;
    • Aki, Fuminori;
    • Yamada, Tomomi;
    • Morita, Satoshi;
    • Nakayama, Takahiro
    Publication type:
    Article
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46

    CDK 4/6 inhibitors and stereotactic radiation in the management of hormone receptor positive breast cancer brain metastases.

    Published in:
    Journal of Neuro-Oncology, 2019, v. 144, n. 3, p. 583, doi. 10.1007/s11060-019-03260-6
    By:
    • Figura, Nicholas B.;
    • Potluri, Thrisha K.;
    • Mohammadi, Homan;
    • Oliver, Daniel E.;
    • Arrington, John A.;
    • Robinson, Timothy J.;
    • Etame, Arnold B.;
    • Tran, Nam D.;
    • Liu, James K.;
    • Soliman, Hatem;
    • Forsyth, Peter A.;
    • Sahebjam, Solmaz;
    • Yu, H. Michael;
    • Han, Hyo S.;
    • Ahmed, Kamran A.
    Publication type:
    Article
    47
    48
    49
    50

    Different dosage forms of gonadotropin-releasing hormone agonist with endocrine therapy in premenopausal hormone receptor–positive breast cancer.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 10, p. 1587, doi. 10.1093/jnci/djae115
    By:
    • Lin, Jinna;
    • Ouyang, Yiye;
    • Li, Yudong;
    • Jin, Liang;
    • Li, Shunying;
    • Liu, Yujie;
    • Yang, Yaping;
    • Shi, Qianfeng;
    • Zhu, Mengdi;
    • Cai, Zijie;
    • Wang, Jingru;
    • Liu, Nianqiu;
    • Hu, Yue;
    • Wu, Zongqi;
    • Wu, Mengzi;
    • Wong, Lok Lam;
    • Jiang, Xiaoting;
    • Wang, Qi;
    • Yang, Wang;
    • Liu, Qiang
    Publication type:
    Article